FRTX
Fresh Tracks Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
brickell biotech, inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases. our management team and board of directors has extensive experience in product development, having served in leadership roles at several pharmaceutical and successful start-up companies. our strategy is to leverage this experience to in-license, acquire, develop and commercialize products that we believe can be successful in the global dermatology marketplace. our portfolio of five product candidates, all new molecular entities with relevant mechanism of actions in skin diseases, targets significant market opportunities.
Market Cap: 4.84 Million
Primary Exchange: NASDAQ
Website: https://brickellbio.com/
Shares Outstanding: 5.97 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.6732219659190419
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Ethical Flags
Longest drawdown: 253 trading days
From: 2023-01-27 To: 2023-12-18
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|